The Role of Cardiopulmonary Exercise Test in IPF Prognosis
Table 1
Demographic and clinical data of the study population.
Variables ()
(mean ± SD)
Age, year ()
67.5 (±8.3)
Gender (M/F)
17/8
Ex-smoker () %
13 (52%)
Non smoker () %
11 (44%)
Smoker () %
1 (4%)
PY (mean ± SD)
25.4 (±34.2)
FEV1% ()
80.4 ± 18.8
FVC% ()
77.5 ± 21.8
FEV1%/FVC ()
82 ± 0.04
TLC% ()
61.4 ± 13.7
DLCO% ()
45.6 ± 13.2
Comorbid disease ()
Arterial hypertension
10 (40%)
Coronary disease
4 (16%)
Diabetes mellitus
3 (12%)
Gastroesophageal reflux symptoms
5 (20%)
M/F: male/female, PY: pack/years, FEV1: forced expiratory volume at one second, FVC: forced vital capacity, TLC: total lung capacity, and DLCO: diffusing capacity for carbon monoxide. All values are shown as mean ± standard deviation (SD).
